BioNTech SE
—Price / book
Market cap
$26.06B
Tangible equity
—
Price / tangible book
—
Price / book
—
Return on equity
—
Return on assets
-5.2%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $26.06B · View financials
Snapshot Sep 4, 4:00 PM ET
Decision snapshot: BNTX stock price vs FCNCA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FCNCA's multiple
Needs Book value / share.
Implied fair value · at BNTX's multiple
Needs BNTX P/B.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Higher is better
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: BNTX FY 2025 (ended Dec 31, 2025) · FCNCA FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$26.06B
Tangible equity
—
Price / tangible book
—
Price / book
—
Return on equity
—
Return on assets
-5.2%
Efficiency ratio
—
Price / tangible book
Market cap
$25.90B
Tangible equity
$21.70B
Price / tangible book
1.19x
Price / book
1.16x
Return on equity
9.9%
Return on assets
1.0%
Efficiency ratio
41.8%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BioNTech SE · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
FIRST CITIZENS BANCSHARES INC /DE/ · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
1.62x
Net debt / EBITDA
Leverage against operating earnings
4.45x
—
Cash and equivalents
Liquid reserves on the balance sheet
$7.68B
—
Total debt
Interest-bearing obligations outstanding
$2.68B
$36.01B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Moderna, Inc.
BNTX vs MRNA
GILEAD SCIENCES, INC.
BNTX vs GILD
AMGEN INC
BNTX vs AMGN
REGENERON PHARMACEUTICALS, INC.
BNTX vs REGN
INCYTE CORP
BNTX vs INCY
VERTEX PHARMACEUTICALS INC / MA
BNTX vs VRTX
JPMorgan Chase & Co.
BNTX vs JPM
Bank of America Corporation
BNTX vs BAC
Wells Fargo & Company
BNTX vs WFC
Citigroup Inc.
BNTX vs C
PNC Financial Services Group, Inc.
BNTX vs PNC
Truist Financial Corporation
BNTX vs TFC
U.S. Bancorp
BNTX vs USB
Huntington Bancshares Incorporated
BNTX vs HBAN
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.